Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Silo Pharma Inc (SILO)

Silo Pharma Inc (SILO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SILO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1450 +28.28%
on 07/30/21
0.2486 -25.18%
on 07/06/21
-0.0441 (-19.17%)
since 07/02/21
3-Month
0.1450 +28.28%
on 07/30/21
0.3100 -40.00%
on 05/14/21
-0.0641 (-25.63%)
since 05/05/21
52-Week
0.1450 +28.28%
on 07/30/21
0.6000 -69.00%
on 08/10/20
-0.3080 (-62.35%)
since 07/28/20

Most Recent Stories

More News
Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin

SILO : 0.1860 (+7.20%)
Silo Pharma To Appear On National Media Broadcast on Psychedelics

Silo Pharma, Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, has announced that the company will be participating in a nationwide...

SILO : 0.1860 (+7.20%)
Silo Pharma Enters into Sponsored Research Agreement with the University of Maryland, Baltimore

Silo Pharma, Inc. (OTCQB: SILO), a development stage biopharmaceutical company, today announced that it has entered into a Scientific Research Agreement with the University of Maryland, Baltimore.

SILO : 0.1860 (+7.20%)
Silo Pharma extends agreement for experimental Rheumatoid Arthritis nanoparticle homing peptide

EQNX::TICKER_START (Other OTC:SILO),(OTC US:SILO), EQNX::TICKER_END

SILO : 0.1860 (+7.20%)
Why the North America Psychedelic Drugs Market is Expected to Grow With the Fastest CAGR for Next Several Years

/PRNewswire/ -- The illegal drugs of the 1960's are becoming highly valued drugs for various new therapeutic uses across a growing list of maladies. The door of previously prohibited drugs has been opening...

SILO : 0.1860 (+7.20%)
CMPS : 32.86 (+0.37%)
MNMD : 2.97 (+1.71%)
CLXPF : 3.0200 (-1.31%)
LKYSF : 0.7720 (+0.42%)
NUMI.VN : 0.960 (-1.03%)
OPTI.CN : 0.720 (unch)
OPTHF : 0.5756 (+0.98%)
Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson's and Bipolar Patients

Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research...

SILO : 0.1860 (+7.20%)
Psychedelic Drug Market Has Become a Billion Dollar Industry As Acceptable Treatments Expand

, /PRNewswire/ -- Recently, the use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post-traumatic stress disorder and other related uses....

LKYSF : 0.7720 (+0.42%)
SILO : 0.1860 (+7.20%)
CMPS : 32.86 (+0.37%)
MNMD : 2.97 (+1.71%)
NUMI.VN : 0.960 (-1.03%)
CLXPF : 3.0200 (-1.31%)
Silo Pharma Submits Application for NASDAQ up-listing

Silo Pharma, Inc. (OTCQB: SILO) a development stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has submitted its initial application to...

SILO : 0.1860 (+7.20%)
Silo Pharma announces important milestone. Investigator led study using Psilocybin to treat Parkinson's disease has been submitted for ethics board review.

Silo Pharma, Inc. (OTCQB: SILO) a development stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announced that its investigator led study using Psilocybin to...

SILO : 0.1860 (+7.20%)
Why Companies Are Betting Big On Psychedelic Drugs To Treat Mental Health Epidemic

, /PRNewswire/ -- Psychedelic medicine is having a moment. Once dismissed as a "party drug" for its hallucinogenic effects, ketamine is emerging as a novel alternative treatment for depression. For most,...

SILO : 0.1860 (+7.20%)
MNMD : 2.97 (+1.71%)
CMPS : 32.86 (+0.37%)
TRIP.CN : 0.265 (-1.85%)
TRUFF : 0.2113 (+0.05%)
SHRM.CN : 0.490 (-10.91%)
SHRMF : 0.4031 (+22.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.1922
2nd Resistance Point 0.1884
1st Resistance Point 0.1810
Last Price 0.1860
1st Support Level 0.1698
2nd Support Level 0.1660
3rd Support Level 0.1586

See More

52-Week High 0.6000
Fibonacci 61.8% 0.4262
Fibonacci 50% 0.3725
Fibonacci 38.2% 0.3188
Last Price 0.1860
52-Week Low 0.1450

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar